Evidence map›Paper›PMID 25649546›Full record

ReviewBioMed research international2015

Spasticity and its contribution to hypertonia in cerebral palsy.

Lynn Bar-On, Guy Molenaers, Erwin Aertbeliën, Anja Van Campenhout, Hilde Feys, Bart Nuttin, Kaat Desloovere

6 registry-linked trialsOpen access · hybridAbstract readReview
In one paragraph

Review in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 6 registered trials, which are not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05113433 naunknown statusnot on this mapstarted 2021, after this paper: background citation

Effects of Different Time Period of Standing Frame on Spasticity and Gait in Children With Spastic Cerebral Palsy.

TypeinterventionalSponsorShifa Tameer-e-Millat UniversityRan2021 to 2021Enrolled60ConditionsSpastic Cerebral Palsy, Spastic GaitArmsconventional physical therapy, standing frame.
NCT05857280 naunknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of EXOPULSE Mollii Suit on Motor Functions in Patients With Multiple Sclerosis (EXOSEP 2)

TypeinterventionalSponsorSheikh Shakhbout Medical CityRan2023 to 2025Enrolled36ConditionsSclerosis, Multiple, MS (Multiple Sclerosis), Spasticity, Muscle, SpasticArmsEXOPULSE Mollii Suit Stimulation
NCT05912595 naunknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of EXOPULSE Mollii Suit on Spasticity and Muscular Oxygenation in Patients With Multiple Sclerosis.

TypeinterventionalSponsorSheikh Shakhbout Medical CityRan2023 to 2024Enrolled36ConditionsSclerosis, Multiple, MS (Multiple Sclerosis), Spastic, Spasticity, MuscleArmsEXOPULSE Mollii Suit Stimulation
NCT06214975 naunknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of EXOPULSE Mollii Suit on Motor Functions in Patients With Stroke (EXOSTROKE 2)"

TypeinterventionalSponsorSheikh Shakhbout Medical CityRan2023 to 2024Enrolled36ConditionsStroke, Spasticity, Muscle, SpasticArmsEXOPULSE Mollii Suit Stimulation
NCT06838858 naactive not recruitingnot on this mapstarted 2024, after this paper: background citation

Investigation of the Early Effects of Motor Imagery Training on Balance, Walking and Quality of Life After Ankle Plantar Flexor Muscle Lengthening Surgery in Children With Cerebral Palsy

TypeinterventionalSponsorSaglik Bilimleri UniversitesiRan2024 to 2025Enrolled28ConditionsRehabilitation, Cerebral Palsy (CP), Exercise, TenotomyArmsMotor Imagery Training, Conventional Post-operative Exercises
NCT07567053 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

6-Hz Primed Low and High-Frequency Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Children With Cerebral Palsy: TMS-EEG Study

TypeinterventionalSponsorCook Children's Health Care SystemRan2026 to 2030Enrolled60ConditionsCerebral Palsy, Typically Developing ChildrenArmsMRI, HD-EEG Recording, rTMS
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 154 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Lynn Bar-OnKU Leuven Department of Rehabilitation Sciences, 3000 Leuven, Belgium ; Clinical Motion Analysis Laboratory, University Hospital Leuven, 3212 Pellenberg, Belgium.ORCID 0000-0003-4793-2860
Guy MolenaersClinical Motion Analysis Laboratory, University Hospital Leuven, 3212 Pellenberg, Belgium ; KU Leuven Department of Development and Regeneration, 3000 Leuven, Belgium ; Department of Orthopedics, University Hospital Leuven, 3212 Pellenberg, Belgium.
Erwin AertbeliënKU Leuven Department of Mechanical Engineering, 3000 Leuven, Belgium.
Anja Van CampenhoutKU Leuven Department of Development and Regeneration, 3000 Leuven, Belgium ; Department of Orthopedics, University Hospital Leuven, 3212 Pellenberg, Belgium.
Hilde FeysKU Leuven Department of Rehabilitation Sciences, 3000 Leuven, Belgium.
Bart NuttinKU Leuven Department of Neurosciences, 3000 Leuven, Belgium ; Department of Neurosurgery, University Hospital Leuven, 3000 Leuven, Belgium.ORCID 0000-0003-0439-8215
Kaat DesloovereKU Leuven Department of Rehabilitation Sciences, 3000 Leuven, Belgium ; Clinical Motion Analysis Laboratory, University Hospital Leuven, 3212 Pellenberg, Belgium.
KU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability of clinical tests to differentiate between the neural (e.g., spasticity) and nonneural (e.g., soft tissue properties) contributions to hypertonia, leading to the terms "spasticity" and "hypertonia" often being used interchangeably. Recent advancements in instrumented spasticity assessments offer objective measurement methods for distinction and quantification of hypertonia components. These methods can be applied in clinical settings and their results used to fine-tune and improve treatment. We reviewed current advancements and new insights with respect to quantifying spasticity and its contribution to muscle hypertonia in children with CP. First, we revisit what is known about spasticity in children with CP, including the various definitions and its pathophysiology. Second, we summarize the state of the art on instrumented spasticity assessment in CP and review the parameters developed to quantify the neural and nonneural components of hypertonia. Lastly, the impact these quantitative parameters have on clinical decision-making is considered and recommendations for future clinical and research investigations are discussed.

Indexed as

AnimalsCerebral PalsyHumansMuscle HypertoniaMuscle SpasticityNeurons

Identifiers

PMID25649546
PMCPMC4306250
OpenAlexW2008898412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.